We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.42B
AUM Growth
-$3.38B
Cap. Flow
-$3.75B
Cap. Flow %
-69.25%
Top 10 Hldgs %
40.63%
Holding
1,042
New
84
Increased
109
Reduced
414
Closed
284
Avg Time Held Equity + Options
3.7 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
3.7 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$184M
2
STOR
STORE Capital Corporation
STOR
+$172M
3
FHN icon
First Horizon
FHN
+$107M
4
COUP
Coupa Software Incorporated
COUP
+$96.9M
5
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
+$64.6M

Top Sells

Rank Stock Value
1
BHVN icon
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$572M
2
ZEN
ZENDESK INC
ZEN
+$456M
3
AVLR
Avalara, Inc.
AVLR
+$373M
4
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$271M
5
ROG icon
Rogers Corp
ROG
+$219M

Sector Composition

Rank Sector Weight
1 Financials 25.7%
2 Technology 18.31%
3 Healthcare 15.11%
4 Miscellaneous 11.75%
5 Real Estate 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ORTX
626
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$161K ﹤0.01%
43,298
– –
2022 Q1
3 quarters
ESPR icon
627
CALL
DELISTED
Esperion Therapeutics
ESPR
$158K ﹤0.01%
+125,000
New +$894K
2022 Q4
0 quarters
RONI.WS
628
DELISTED
Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
RONI.WS
$150K ﹤0.01%
118,155
-1,156
-1% -$522
2021 Q3
5 quarters
INZY icon
629
DELISTED
Inozyme Pharma
INZY
$148K ﹤0.01%
140,623
-24,875
-15% -$43.5K
2022 Q2
2 quarters
M icon
630
PUT
Macy's
M
$5.94B
$144K ﹤0.01%
164,500
– –
2021 Q2
6 quarters
MPT icon
631
PUT
Medical Properties Trust
MPT
$1.87B
$140K ﹤0.01%
+800,000
New +$9.3M
2022 Q4
0 quarters
SVC
632
PUT
Service Properties Trust
SVC
$767M
$138K ﹤0.01%
93,500
– –
2021 Q2
6 quarters
NAVI icon
633
PUT
Navient
NAVI
$883M
$124K ﹤0.01%
107,800
– –
2021 Q2
6 quarters
DOCN icon
634
PUT
DigitalOcean
DOCN
$15.1B
$111K ﹤0.01%
+50,000
New +$1.57M
2022 Q4
0 quarters
NGL icon
635
PUT
NGL Energy Partners
NGL
$1.87B
$108K ﹤0.01%
81,300
– –
2021 Q2
6 quarters
THC icon
636
PUT
Tenet Healthcare
THC
$21.5B
$106K ﹤0.01%
39,800
-10,200
-20% -$471K
2021 Q4
4 quarters
OMF icon
637
PUT
OneMain Financial
OMF
$6.45B
$104K ﹤0.01%
27,900
– –
2022 Q3
1 quarter
NHICW
638
DELISTED
NewHold Investment Corp. II Warrant
NHICW
$103K ﹤0.01%
891,915
– –
2021 Q4
4 quarters
HPX.WS
639
DELISTED
HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HPX.WS
$103K ﹤0.01%
261,507
– –
2022 Q1
3 quarters
TGI icon
640
PUT
DELISTED
Triumph Group
TGI
$83K ﹤0.01%
30,600
-3,800
-11% -$39.3K
2021 Q2
6 quarters
CPE
641
PUT
DELISTED
Callon Petroleum Company
CPE
$80K ﹤0.01%
78,700
– –
2021 Q2
6 quarters
CONXW icon
642
DELISTED
CONX Corp. Warrant
CONXW
$78K ﹤0.01%
470,613
-4,625
-1% -$762
2021 Q1
7 quarters
ADT icon
643
PUT
ADT
ADT
$4.83B
$59K ﹤0.01%
90,300
– –
2021 Q2
6 quarters
RIG icon
644
PUT
Transocean
RIG
$6.31B
$59K ﹤0.01%
1,967,700
– –
2018 Q2
18 quarters
HZNP
645
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$55K ﹤0.01%
+12,500
New +$1.04M
2022 Q4
0 quarters
DTRTW
646
DELISTED
DTRT Health Acquisition Corp. Warrant
DTRTW
$53K ﹤0.01%
+190,798
New +$45.9K
2022 Q4
0 quarters
RDN icon
647
PUT
Radian Group
RDN
$4.47B
$41K ﹤0.01%
31,500
– –
2021 Q2
6 quarters
MAT icon
648
CALL
Mattel
MAT
$4.8B
$38K ﹤0.01%
+500,000
New +$9.07M
2022 Q4
0 quarters
RVNC icon
649
PUT
DELISTED
Revance Therapeutics, Inc.
RVNC
$38K ﹤0.01%
100,000
– –
2022 Q1
3 quarters
BOAC.WS
650
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
$35K ﹤0.01%
231,631
-2,273
-1% -$289
2021 Q1
7 quarters
24 25
26
27 28

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 1,042 positions worth $5.42B, down 38% from $8.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $3.75B in Q4 2022, closing 284 positions and reducing 414 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Coupa Software Incorporated worth $128M.

  • UBS O'Connor's largest Q4 2022 buy was Coupa Software Incorporated: 1,619,333 shares worth $128M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Rogers Corp, cutting an estimated $219M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 41% of its $5.42B portfolio in Q4 2022.
  • UBS O'Connor opened 84 new positions and closed 284 in Q4 2022.
  • UBS O'Connor's portfolio value fell 38% quarter-over-quarter to $5.42B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.